Free Trial

ACADIA Pharmaceuticals (ACAD) SEC Filings & 10K Form

$18.13
+0.38 (+2.14%)
(As of 07/22/2024 ET)

Recent ACADIA Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/11/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:23 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form DEF 14A
04/15/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:58 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:02 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:57 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:07 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:10 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:13 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:08 AM
ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
02/09/2024
7:35 AM
ACADIA Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
4:05 PM
ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2024
4:09 PM
ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
8:55 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
6:37 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
11:46 AM
ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
4:32 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:11 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:30 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Kiss of death from Joe Biden (Ad)

As you’ll discover, behind closed doors in D.C. the elites have manufactured a shocking new economic and social crisis that threatens everything. Elon Musk calls it “staggering.”

To get all the details, click here to stream this new documentary.
10/06/2023
9:00 PM
ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
8:59 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
5:31 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
12:06 PM
ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
6:31 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
10:15 AM
ACADIA Pharmaceuticals (Subject)
Schneyer Mark C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ACAD) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners